午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

湖北摩科化學(xué)有限公司 Company Information
Company Name:    Hubei Moco Chemical Co., Ltd.
Tel:    -18627753421
Email:    3001051413@qq.com
Nationality:    China
WebSite:    http://www.molcoo.com/
Product List:    19357
181 182 183 184 185 186 187 188 189 190 191 192 193 194
Product List
4-hydroxy-2-nitropyrimidine 101654-28-8
Larotinib Impurity 6 1223404-88-3
Larotinib 1223403-58-4
Larotinib Impurity 7 1223404-68-9
Palonosetron Impurity 35 98841-72-6
Ligagliptin Impurity 66 2434-53-9
Palonosetron Impurity 37 91245-72-6
Benzyl magnesium chloride 6921-34-2
Larotinib Impurity 5 2409589-59-7
Acetazolamide EP Impurity C 32873-56-6
Acetazolamide EP Impurity E 827026-60-8
Tigola produced Impurity 19 942195-86-0
Aboxitinib-related compounds 1 1353501-22-0
Aboxitinib 1622902-68-4
Tigora produced impurity 18 942195-83-7
Tigora produced impurity 17 774582-60-4
Timolol impurity 18 158636-99-8
Metaramine bitartrate impurity 31 26607-51-2
Metaramine bitartrate Impurity 40 2151127-61-4
Odatero Impurity 6 861841-90-9
2-(2-bromophenyl) methyl acetate 57486-69-8
Dozolamine EP Impurity B(hydrochloride) 120279-37-0
Roxastat Impurity 24 1509958-20-6
Tigola produced impurity 5 1640981-19-6
Metaramine bitartrate Impurity 30 1142-20-7
Tigora produces impurity 1 39269-74-4
Dozolamine EP Impurity A(hydrochloride) 122028-36-8
Vitamin D3 EP Impurity E(Tachysterol 3) 17592-07-3
Tigora produced impurity 2 1640981-02-7
Pioglitazone hydrochloride 112529-15-4
Butyl 4-hydroxybenzoate 94-26-8
Acetazolamide impurity 11 50608-12-3
Adapalene impurity 12 726-94-3
Acetazolamide EP Impurity B 5393-55-5
Vigliptin Impurity 59 1382839-19-1
Nematvir Impurity 14 741267-75-4
Duensibu 1201438-56-3
Acetazolamide EP Impurity G 2349-67-9
Acetazolamide Impurity 8 32873-57-7
Nematvir Impurity 3 2755812-81-6
Sodium amino 7782-92-5
Acetazolamide EP Impurity D 14949-00-9
Nematvir Impurity 15 328086-60-8
Larotinib Impurity 1 1217630-38-0
Sertraline impurity 34 36159-73-6
Larotinib Impurity 4 2409590-08-3
Nematwe 2628280-40-8
Acetazolamide 59-66-5
Palonosetron Impurity 36 66377-63-7
Acetazolamide impurity 9 99055-56-8
Acetazolamide EP Impurity F 80495-47-2
O-demethyladaparine 125316-60-1
Nematvir Impurity 12 2755812-45-2
Aboxitinib-related Compound 3 1622980-99-7
Nematavir Impurity 16 (hydrochloride) 2628280-48-6
Larotinib Impurity 2 29274-24-6
Acetazolamide EP Impurity A 60320-32-3
Larotinib Impurity 1 (hydrochloride) 1443624-23-4
Larotinib sulfate 1223405-08-0
Roxatidine acetate (hydrochloride) 93793-83-0
Alagliptin 739366-20-2
Dozolamine hydrochloride 130693-82-2
Odatero Impurity 5 861841-94-3
Odatero Impurity 14 926319-54-2
Isopropyl ethanesulfonate 14245-62-6
Metoclopramide impurity 12 20896-27-9
Odarol (hydrochloride) 869477-96-3
Odaro 868049-49-4
Tenofovir impurity 116 58989-06-3
Tigorasan 942195-55-3
Tigora produces impurity 6 1640981-20-9
Metaramine bitartrate impurity 43 47017-06-1
Thiosalicylic acid 147-93-3
Metaramine bitartrate Impurity 33 53087-13-1
Vitamin D3 caprate 158180-04-2
Methyl 2-(3-bromophenyl) acetate 150529-73-0
Odatero Impurity 4 30992-63-3
Tigola produces impurity 10 844648-22-2
Pramexol Impurity 56 1373869-89-6
Roxastat Impurity 14 1455091-10-7
Roxastat Impurity 26 1421312-34-6
Odatero Impurity 12 869478-13-7
Calcitadiol EP Impurity B 22145-68-2
Vitamin D3 caprylate 927822-16-0
Tigora produced impurity 3 1640981-16-3
Metaramine bitartrate impurity 32 425387-07-1
Piracetam Impurity 8 7060-52-8
(S) -1-mesylate -1, 2-propylene glycol 262423-83-6
Metaramine bitartrate 29 946-80-5
(4S,6R) -dozolamine EP impurity B 139066-77-6
3-chloro-2, 2-dimethyl-1-propanol 13401-56-4
Tigora produces impurity 7 2713-34-0
Chlorhexidine EP impurity A 152504-08-0
Dronedarone hydrochloride 141625-93-6
Donepezil Impurity 39 120013-56-1
1, 4-dibutoxy-benzene 104-36-9
4-n-butoxy-phenol 122-94-1
Azisartan Impurity 104 1417576-02-3
Primocaine hydrochloride 637-58-1
Celodoxin Impurity 6 1453221-45-8
181 182 183 184 185 186 187 188 189 190 191 192 193 194
Copyright 2007©  ChemicalBook. All rights reserved.